ATE206056T1 - Therapeutisches agens für neutropenie - Google Patents

Therapeutisches agens für neutropenie

Info

Publication number
ATE206056T1
ATE206056T1 AT93108975T AT93108975T ATE206056T1 AT E206056 T1 ATE206056 T1 AT E206056T1 AT 93108975 T AT93108975 T AT 93108975T AT 93108975 T AT93108975 T AT 93108975T AT E206056 T1 ATE206056 T1 AT E206056T1
Authority
AT
Austria
Prior art keywords
neutropenia
treatment
pharmaceutical compositions
therapeutic agent
present
Prior art date
Application number
AT93108975T
Other languages
English (en)
Inventor
Tatsuya Watanabe
Sumie Yoshitomi
Sasada Reiko
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE206056T1 publication Critical patent/ATE206056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT93108975T 1992-06-08 1993-06-04 Therapeutisches agens für neutropenie ATE206056T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14774992 1992-06-08

Publications (1)

Publication Number Publication Date
ATE206056T1 true ATE206056T1 (de) 2001-10-15

Family

ID=15437279

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93108975T ATE206056T1 (de) 1992-06-08 1993-06-04 Therapeutisches agens für neutropenie

Country Status (5)

Country Link
US (1) US6015552A (de)
EP (1) EP0573904B1 (de)
AT (1) ATE206056T1 (de)
CA (1) CA2097878C (de)
DE (1) DE69330809T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523105A (en) * 2000-06-22 2004-07-30 Genentech Inc Agonist anti-trk-C monoclonal antibodies
ATE411038T1 (de) 2003-03-28 2008-10-15 Univ Laval S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
CN1897977A (zh) * 2003-10-20 2007-01-17 Ns基因公司 帕金森氏病的体内基因治疗
CN112409471B (zh) * 2016-04-13 2022-07-29 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
US5288487A (en) * 1989-02-28 1994-02-22 Morinaga Milk Industry Co., Ltd. Human monocyte-macrophage-CSF preparations
US6709837B1 (en) * 1989-03-10 2004-03-23 Takeda Chemical Industries, Inc. Polypeptide and production thereof
GR1000980B (el) * 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
US5229500A (en) * 1989-08-30 1993-07-20 Regeneron Pharmaceuticals, Inc. Brain derived neurotrophic factor
IT1239271B (it) * 1990-02-27 1993-10-01 Fidia Spa Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
US5169764A (en) * 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5488099A (en) * 1992-03-06 1996-01-30 Persson, Deceased; Hakan B. Multifunctional chimeric neurotrophic factors

Also Published As

Publication number Publication date
EP0573904B1 (de) 2001-09-26
DE69330809T2 (de) 2002-05-16
DE69330809D1 (de) 2001-10-31
EP0573904A1 (de) 1993-12-15
CA2097878C (en) 2006-08-22
CA2097878A1 (en) 1993-12-09
US6015552A (en) 2000-01-18

Similar Documents

Publication Publication Date Title
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
DE69333321D1 (de) Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten.
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DE69835435D1 (de) Anti-arrhythmische zusammensetzungen und behandlungsverfahren
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
DE69330809D1 (de) Therapeutisches Agens für Neutropenie
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE311897T1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
DE69206665D1 (de) Mittel zur topischen Behandlung von Verbrennungen
SU1553129A1 (ru) Способ лечени альгоменореи
KR890001555A (ko) 요산 배설용 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties